The Liberation From Acute Dialysis (LIBERATE-D) randomized clinical trial tested the value of a conservative vs conventional hemodialysis strategy on recovery of kidney function in stable patients ...
Vexev, an Australian-based medical device company advancing next-generation vascular imaging, and U.S. Renal Care, a leading provider of in-center and home dialysis in the United States, announced the ...